Beauty Health Co

Beauty Health CoSKINEarnings & Financial Report

Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus

Rare Beauty is an American cosmetics company founded by singer and actress Selena Gomez. Launched on September 3, 2020, the brand takes its name from Gomez’s third studio album, Rare (2020). Rare Beauty is sold through its official website, Sephora And Ulta beauty stores in multiple regions, including North America, Europe, Asia, and the Middle East.

SKIN Q4 FY2025 Key Financial Metrics

Revenue

$82.4M

Gross Profit

$53.0M

Operating Profit

$162.0K

Net Profit

$-8.1M

Gross Margin

64.4%

Operating Margin

0.2%

Net Margin

-9.8%

YoY Growth

-1.3%

EPS

$-0.02

Beauty Health Co Q4 FY2025 Financial Summary

Beauty Health Co reported revenue of $82.4M (down 1.3% YoY) for Q4 FY2025, with a net profit of $-8.1M (up 21.5% YoY) (-9.8% margin). Cost of goods sold was $29.3M, operating expenses totaled $52.9M.

Key Financial Metrics

Total Revenue$82.4M
Net Profit$-8.1M
Gross Margin64.4%
Operating Margin0.2%
Report PeriodQ4 FY2025

Revenue Breakdown

Beauty Health Co Q4 FY2025 revenue of $82.4M breaks down across 2 segments, led by Consumables at $57.7M (70.0% of total).

SegmentRevenue% of Total
Consumables$57.7M70.0%
Delivery Systems$24.7M30.0%

Beauty Health Co Revenue by Segment — Quarterly Trend

Beauty Health Co revenue by segment across the last 4 reported quarters, showing how each business line (such as Consumables and Delivery Systems) has evolved quarter over quarter.

SegmentQ4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025
Consumables$57.7M$49.8M$55.8M$49.4M
Delivery Systems$24.7M$20.8M$22.4M$20.2M

Beauty Health Co Annual Revenue by Year

Beauty Health Co annual revenue history includes year-by-year totals (for example, 2025 revenue was $300.8M).

YearAnnual Revenue
2025$300.8Mvs 2024
2024$334.3Mvs 2023
2023$398.0Mvs 2022
2022$365.9M

Beauty Health Co Quarterly Revenue & Net Profit History

Beauty Health Co results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 FY2025$82.4M-1.3%$-8.1M-9.8%
Q3 FY2025$70.7M-10.3%$-11.0M-15.6%
Q2 FY2025$78.2M-13.7%$19.7M25.2%
Q1 FY2025$69.6M-14.5%$-10.1M-14.5%
Q4 FY2024$83.5M-13.8%$-10.3M-12.4%
Q3 FY2024$78.8M-19.1%$-18.3M-23.2%
Q2 FY2024$90.6M-22.9%$202.0K0.2%
Q1 FY2024$81.4M-5.7%$-679.0K-0.8%

Income Statement

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue$81.4M$90.6M$78.8M$83.5M$69.6M$78.2M$70.7M$82.4M
YoY Growth-5.7%-22.9%-19.1%-13.8%-14.5%-13.7%-10.3%-1.3%

Balance Sheet

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Assets$844.7M$711.8M$699.5M$685.7M$673.8M$507.6M$503.6M$499.8M
Liabilities$781.4M$642.6M$639.8M$633.9M$627.8M$433.6M$438.0M$438.7M
Equity$63.3M$69.2M$59.7M$51.8M$46.1M$74.0M$65.7M$61.1M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Operating CF$-16.9M$6.2M$10.3M$16.5M$3.0M$9.6M$9.6M$15.2M